| Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease A Mehlem, CE Hagberg, L Muhl, U Eriksson, A Falkevall Nature protocols 8 (6), 1149-1154, 2013 | 867 | 2013 |
| Vascular endothelial growth factor B controls endothelial fatty acid uptake CE Hagberg, A Falkevall, X Wang, E Larsson, J Huusko, I Nilsson, ... Nature 464 (7290), 917-921, 2010 | 576 | 2010 |
| Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes CE Hagberg, A Mehlem, A Falkevall, L Muhl, BC Fam, H Ortsäter, ... Nature 490 (7420), 426-430, 2012 | 315 | 2012 |
| Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1–and neuropilin receptor-1 … JE Lähteenvuo, MT Lähteenvuo, A Kivelä, C Rosenlew, A Falkevall, ... Circulation 119 (6), 845-856, 2009 | 242 | 2009 |
| Degradation of the amyloid β-protein by the novel mitochondrial peptidasome, PreP*♦ A Falkevall, N Alikhani, S Bhushan, PF Pavlov, K Busch, KA Johnson, ... Journal of Biological Chemistry 281 (39), 29096-29104, 2006 | 238 | 2006 |
| Reducing VEGF-B signaling ameliorates renal lipotoxicity and protects against diabetic kidney disease A Falkevall, A Mehlem, I Palombo, BH Sahlgren, L Ebarasi, L He, ... Cell Metabolism 25 (3), 713-726, 2017 | 165 | 2017 |
| Characterization of a novel zinc metalloprotease involved in degrading targeting peptides in mitochondria and chloroplasts P Moberg, A Ståhl, S Bhushan, SJ Wright, AC Eriksson, BD Bruce, ... The Plant Journal 36 (5), 616-628, 2003 | 127 | 2003 |
| Isolation and identification of a novel mitochondrial metalloprotease (PreP) that degrades targeting presequences in plants A Ståhl, P Moberg, J Ytterberg, O Panfilov, HB Von Lowenhielm, F Nilsson, ... Journal of Biological Chemistry 277 (44), 41931-41939, 2002 | 113 | 2002 |
| The closed structure of presequence protease PreP forms a unique 10 000 Å3 chamber for proteolysis KA Johnson, S Bhushan, A Ståhl, BM Hallberg, A Frohn, E Glaser, ... The EMBO journal 25 (9), 1977-1986, 2006 | 104 | 2006 |
| Dual targeting and function of a protease in mitochondria and chloroplasts S Bhushan, B Lefebvre, A Ståhl, SJ Wright, BD Bruce, M Boutry, E Glaser EMBO reports 4 (11), 1073-1077, 2003 | 97 | 2003 |
| Endothelial fatty acid transport: role of vascular endothelial growth factor B C Hagberg, A Mehlem, A Falkevall, L Muhl, U Eriksson Physiology 28 (2), 125-134, 2013 | 88 | 2013 |
| Two novel targeting peptide degrading proteases, PrePs, in mitochondria and chloroplasts, so similar and still different A Ståhl, S Nilsson, P Lundberg, S Bhushan, H Biverståhl, P Moberg, ... Journal of Molecular Biology 349 (4), 847-860, 2005 | 85 | 2005 |
| Catalysis, Subcellular Localization, Expression and Evolution of the Targeting Peptides Degrading Protease, AtPreP2 S Bhushan, A Ståhl, S Nilsson, B Lefebvre, M Seki, C Roth, D McWilliam, ... Plant and cell physiology 46 (6), 985-996, 2005 | 73 | 2005 |
| PGC-1α coordinates mitochondrial respiratory capacity and muscular fatty acid uptake via regulation of VEGF-B A Mehlem, I Palombo, X Wang, CE Hagberg, U Eriksson, A Falkevall Diabetes 65 (4), 861-873, 2016 | 65 | 2016 |
| Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis I Albrecht, L Kopfstein, K Strittmatter, T Schomber, A Falkevall, ... PloS one 5 (11), e14109, 2010 | 65 | 2010 |
| NMR solution structure of the mitochondrial F1β presequence from Nicotiana plumbaginifolia P Moberg, S Nilsson, A Ståhl, AC Eriksson, E Glaser, L Mäler Journal of molecular biology 336 (5), 1129-1140, 2004 | 64 | 2004 |
| Expression of vascular endothelial growth factor (VEGF)-B and its receptor (VEGFR1) in murine heart, lung and kidney L Muhl, C Moessinger, MZ Adzemovic, MH Dijkstra, I Nilsson, ... Cell and tissue research 365, 51-63, 2016 | 56 | 2016 |
| Rapid degradation of the presequence of the F1β precursor of the ATP synthase inside mitochondria A STÅHL, PF PAVLOV, C SZIGYARTO, E GLASER Biochemical Journal 349 (3), 703-707, 2000 | 24 | 2000 |
| Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue A Falkevall, A Mehlem, E Folestad, FC Ning, Ó Osorio-Conles, ... Journal of Hepatology 78 (5), 901-913, 2023 | 22 | 2023 |
| Method of treating diabetic nephropathy by administering antibodies to vascular endothelial growth factor B (VEGF-B) U Eriksson, A Falkevall, A Mehlem US Patent 9,803,008, 2017 | 3 | 2017 |
